ABT · ISSUER CIK 1800
ABBOTT LABORATORIES
Between Aug 1, 2026 and Oct 29, 2026, 5 ABBOTT LABORATORIES insiders reported $0.00 of open-market purchases and $46.9M of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$46.9MInsider selling
−$46.9MNet open-market
Sep 25, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 202617:21 | Sep 23, 2026 | ABT | Director | F · Tax | $103.99 | −52,507 | 81,230 | -39% | $5.5M | ||
| Sep 3, 202618:11 | Sep 2, 2026 | ABT | VICE PRESIDENT AND CONTROLLER | S · Sell | $109.54 | −27 | 24,549 | -0% | −$3K | ||
| Sep 3, 202618:11 | Sep 1, 2026 | ABT | VICE PRESIDENT AND CONTROLLER | F · Tax | $110.36 | −52 | 24,576 | -0% | $6K | ||
| Sep 3, 202618:02 | Sep 1, 2026 | ABT | EVP AND CFO | F · Tax | $110.36 | −388 | 70,784 | -1% | $43K | ||
| Aug 27, 202617:09 | Aug 25, 2026 | ABT | CHAIRMAN AND CEO, Director | S · Sell | $115.85 | −398,832 | 306,461 | -57% | −$46.2M | ||
| Aug 27, 202617:09 | Aug 25, 2026 | ABT | CHAIRMAN AND CEO, Director | M · Exercise | $54.02 | +398,832 | 705,293 | +130% | $21.5M | ||
| Aug 13, 202617:14 | Aug 11, 2026 | ABT | EXECUTIVE VICE PRESIDENT | S · Sell | $109.83 | −5,850 | 70,724 | -8% | −$643K | ||
| Aug 13, 202617:14 | Aug 12, 2026 | ABT | EXECUTIVE VICE PRESIDENT | I · Plan | $107.99 | −12 | 0 | -100% | $1K |